# FDA Inspection 1229611 - Kaiser Foundation Health Plan of the Northwest - January 29, 2024

Source: https://www.keypedia.com/records/fda_inspections/kaiser-foundation-health-plan-of-the-northwest/34c528ed-8abf-4f79-9233-ecc4e92275f0
Source feed: FDA_Inspections

> FDA Inspection 1229611 for Kaiser Foundation Health Plan of the Northwest on January 29, 2024. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1229611
- Company Name: Kaiser Foundation Health Plan of the Northwest
- Inspection Date: 2024-01-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 967597 - 2016-04-21](https://www.keypedia.com/records/fda_inspections/kaiser-foundation-health-plan-of-the-northwest/e6269f87-f2af-48a8-bc10-54828f456423)
- [FDA Inspection 866486 - 2014-02-19](https://www.keypedia.com/records/fda_inspections/kaiser-foundation-health-plan-of-the-northwest/572b1837-b310-43d9-82da-f1a868452b4c)
- [FDA Inspection 696879 - 2010-11-08](https://www.keypedia.com/records/fda_inspections/kaiser-foundation-health-plan-of-the-northwest/7e5ef45b-c362-4b56-8681-51a6018e2bf3)

Company: https://www.keypedia.com/companies/kaiser-foundation-health-plan-of-the-northwest/cef66b05-b222-48a7-a2a8-4738ceb489dc

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d